For instance, the sdAbs commercially available as Nanobody 2Rs15d labeled with 177Lu via diethylenetriaminepentaacetic acid (DTPA) and targeting tumor biomarker HER2 was evaluated in theranostic studies. This evidence concerns the gene ERBB2 and neoplasm.